Hans Hammers, MD, PhD – Driving Immunotherapy Combinations Into the Modern Age of Kidney Cancer Care
Hans Hammers, MD, PhD, is a distinguished professor in the Department of Internal Medicine at UT Southwestern Medical Center. He also serves as a member of the Division of Hematology and Oncology, is a co-leader for clinical research and immunotherapy in the Kidney Cancer Research Program, and is a co-leader of the Experimental Therapeutics Program. Dr. Hammers’ primary research focus centers on the development of innovative immunotherapies for kidney cancer. ...Expert Interviews
Advertisement
Dr. Sonpavde expounds on the current state and momentum of research efforts to advance treatment strategies in MIBC.
Dr. Siefker-Radtke shares the novel targeted therapies for bladder cancer and how they are assessed in combinations.
Dr. Msaouel shares his journey to becoming a world expert in RMC and the clinical trial work he led to improve outcomes.
Katherine Virgo, PhD, MBA, provided insight into ASCO's updated guideline for the management of metastatic prostate cancer.
Michigan Urological Surgery and Improvement Collaborative is an effort to improve patient lives through high-quality care.
A recent study examined safety and efficacy from the ARASENS trial for certain subgroups by disease volume and risk.
Advertisement
